How to Identify the Asymptomatic High-Risk Patient?

Current Problems in Cardiology

Volumn 34, Issue 11, 2009, Pages 539-577

  Schuijf, Joanne D ^a   Achenbach, Stephan ^a   Zoghbi, William A ^a   Boersma, Eric ^a   Raggi, Paolo ^a   Weber, Michael ^a   Nagel, Eike ^a   Narula, Jagat ^a   Wackers, Frans J Th ^a   Poldermans, Don ^a   Bax, Jeroen J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CALCIUM; IODINATED CONTRAST MEDIUM; RADIOISOTOPE;

ALGORITHM; ANGIOCARDIOGRAPHY; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CAROTID ARTERY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CORONARY ARTERY OBSTRUCTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; ECHOCARDIOGRAPHY; HEART FUNCTION; HEART MUSCLE ISCHEMIA; HIGH RISK PATIENT; HUMAN; MOLECULAR IMAGING; MORBIDITY; MORTALITY; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; RISK ASSESSMENT; SCORING SYSTEM; STRESS RADIOGRAPHY;

ADULT; AGED; ALGORITHMS; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CORONARY ANGIOGRAPHY; CORONARY VESSELS; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; RISK ASSESSMENT; YOUNG ADULT;

EID: 70349919634     PISSN: 01462806     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cpcardiol.2009.07.001     Document Type: Article

References (81)

1. Glagov S., Weisenberg E., Zarins C.K., et al. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 316 (1987) 1371-1375
2. Graham I., Atar D., Borch-Johnsen K., et al. European guidelines on cardiovascular disease prevention in clinical practice: Full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil 14 suppl 2 (2007) S1-S113
3. Yusuf S., Hawken S., Ounpuu S., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet 364 (2004) 937-952
4. Conroy R.M., Pyorala K., Fitzgerald A.P., et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: The SCORE project. Eur Heart J 24 (2003) 987-1003
5. Executive summary of the third report of the national cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of high blood cholesterol in adults (Adult Treatment Panel III). J Am Med Assoc 285 (2001) 2486-2497
6. http://framingham.com/heart/, 2008. Internet communication.
7. Conroy R.M., Pyorala K., Fitzgerald A.P., et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: The SCORE project. Eur Heart J 24 (2003) 987-1003
8. Smith Jr. S.C., Jackson R., Pearson T.A., et al. Principles for national and regional guidelines on cardiovascular disease prevention: a scientific statement from the World Heart and Stroke Forum. Circulation 109 (2004) 3112-3121
9. Heeschen C., Hamm C.W., Mitrovic V., et al. N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes. Circulation 110 (2004) 3206-3212
10. Weber M., Dill T., Arnold R., et al. N-terminal B-type natriuretic peptide predicts extent of coronary artery disease and ischemia in patients with stable angina pectoris. Am Heart J 148 (2004) 612-620
11. Weber M., Bazzino O., Navarro Estrada J.L., et al. N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission. J Am Coll Cardiol 51 (2008) 1188-1195
12. Abdullah S.M., Khera A., Das S.R., et al. Relation of coronary atherosclerosis determined by electron beam computed tomography and plasma levels of n-terminal pro-brain natriuretic peptide in a multiethnic population-based sample (the Dallas Heart Study). Am J Cardiol 96 (2005) 1284-1289
13. Blankenberg S., McQueen M.J., Smieja M., et al. Comparative impact of multiple biomarkers and N-terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the heart outcomes prevention evaluation (HOPE) study. Circulation 114 (2006) 201-208
14. Heeschen C., Hamm C.W., Bruemmer J., et al. Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. CAPTURE Investigators. Chimeric c7E3 Antiplatelet Therapy in Unstable angina REfractory to standard treatment trial. J Am Coll Cardiol 35 (2000) 1535-1542
15. James S.K., Armstrong P., Barnathan E., et al. Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a GUSTO-IV substudy. J Am Coll Cardiol 41 (2003) 916-924
16. Lindahl B., Toss H., Siegbahn A., et al. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during instability in coronary artery disease. N Engl J Med 343 (2000) 1139-1147
17. Sabatine M.S., Morrow D.A., Jablonski K.A., et al. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease. Circulation 115 (2007) 1528-1536
18. Schnabel R., Rupprecht H.J., Lackner K.J., et al. Analysis of N-terminal-pro-brain natriuretic peptide and C-reactive protein for risk stratification in stable and unstable coronary artery disease: Results from the AtheroGene study. Eur Heart J 26 (2005) 241-249
19. Ridker P.M., Rifai N., Rose L., et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347 (2002) 1557-1565
20. Ridker P.M., Buring J.E., Rifai N., et al. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: The Reynolds risk score. J Am Med Assoc 297 (2007) 611-619
21. Ridker P.M., Paynter N.P., Rifai N., et al. C-reactive protein and parental history improve global cardiovascular risk prediction: The Reynolds risk score for men. Circulation 118 (2008) 2243-2251 4p
22. Ridker P.M., Danielson E., Fonseca F.A., et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 359 (2008) 2195-2207
23. Rumberger J.A., Sheedy III P.F., Breen J.F., et al. Coronary calcium, as determined by electron beam computed tomography, and coronary disease on arteriogram. Effect of patient's sex on diagnosis. Circulation 91 (1995) 1363-1367
24. Henneman M.M., Schuijf J.D., Pundziute G., et al. Noninvasive evaluation with multislice computed tomography in suspected acute coronary syndrome: Plaque morphology on multislice computed tomography versus coronary calcium score. J Am Coll Cardiol 52 (2008) 216-222
25. Arad Y., Goodman K.J., Roth M., et al. Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: The St. Francis heart study. J Am Coll Cardiol 46 (2005) 158-165
26. Greenland P., LaBree L., Azen S.P., et al. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. J Am Med Assoc 291 (2004) 210-215
27. Lakoski S.G., Greenland P., Wong N.D., et al. Coronary artery calcium scores and risk for cardiovascular events in women classified as "low risk" based on Framingham risk score: the multi-ethnic study of atherosclerosis (MESA). Arch Intern Med 167 (2007) 2437-2442
28. Wong N.D., Rozanski A., Gransar H., et al. Metabolic syndrome and diabetes are associated with an increased likelihood of inducible myocardial ischemia among patients with subclinical atherosclerosis. Diabetes Care 28 (2005) 1445-1450
29. Anand D.V., Lim E., Hopkins D., et al. Risk stratification in uncomplicated type 2 diabetes: Prospective evaluation of the combined use of coronary artery calcium imaging and selective myocardial perfusion scintigraphy. Eur Heart J 27 (2006) 713-721
30. Budoff M.J., Achenbach S., Blumenthal R.S., et al. Assessment of coronary artery disease by cardiac computed tomography: a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology. Circulation 114 (2006) 1761-1791
31. Greenland P., Bonow R.O., Brundage B.H., et al. ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography) developed in collaboration with the Society of Atherosclerosis Imaging and Prevention and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol 49 (2007) 378-402
32. Chambless L.E., Heiss G., Folsom A.R., et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the atherosclerosis risk in communities (ARIC) study, 1987-93. Am J Epidemiol 146 (1997) 483-494
33. O'Leary D.H., Polak J.F., Kronmal R.A., et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 340 (1999) 14-22
34. Lorenz M.W., Markus H.S., Bots M.L., et al. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 115 (2007) 459-467
35. Wyman R.A., Mays M.E., McBride P.E., et al. Ultrasound-detected carotid plaque as a predictor of cardiovascular events. Vasc Med 11 (2006) 123-130
36. Prati P., Tosetto A., Vanuzzo D., et al. Carotid intima Media thickness and plaques can predict the occurrence of ischemic cerebrovascular events. Stroke 39 (2008) 2470-2476
37. Folsom A.R., Kronmal R.A., Detrano R.C., et al. Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: the multi-ethnic study of atherosclerosis (MESA). Arch Intern Med 168 (2008) 1333-1339
38. Abdulla J., Abildstrom S.Z., Gotzsche O., et al. 64-Multislice detector computed tomography coronary angiography as potential alternative to conventional coronary angiography: a systematic review and meta-analysis. Eur Heart J 28 (2007) 3042-3050
39. Vanhoenacker P.K., Heijenbrok-Kal M.H., Van Heste R., et al. Diagnostic performance of multidetector CT angiography for assessment of coronary artery disease: Meta-analysis. Radiology 244 (2007) 419-428
40. Achenbach S., Moselewski F., Ropers D., et al. Detection of calcified and noncalcified coronary atherosclerotic plaque by contrast-enhanced, submillimeter multidetector spiral computed tomography: a segment-based comparison with intravascular ultrasound. Circulation 109 (2004) 14-17
41. Leber A.W., Knez A., Becker A., et al. Accuracy of multidetector spiral computed tomography in identifying and differentiating the composition of coronary atherosclerotic plaques: a comparative study with intracoronary ultrasound. J Am Coll Cardiol 43 (2004) 1241-1247
42. Leber A.W., Becker A., Knez A., et al. Accuracy of 64-slice computed tomography to classify and quantify plaque volumes in the proximal coronary system: a comparative study using intravascular ultrasound. J Am Coll Cardiol 47 (2006) 672-677
43. Pohle K., Achenbach S., MacNeill B., et al. Characterization of non-calcified coronary atherosclerotic plaque by multi-detector row CT: Comparison to IVUS. Atherosclerosis 190 (2006) 174-180
44. Cademartiri F., Mollet N.R., Runza G., et al. Influence of intracoronary attenuation on coronary plaque measurements using multislice computed tomography: observations in an ex vivo model of coronary computed tomography angiography. Eur Radiol 16 (2005) 575-582
45. Narula J., Garg P., Achenbach S., et al. Arithmetic of vulnerable plaques for noninvasive imaging. Nat Clin Pract Cardiovasc Med 5 suppl 2 (2008) S2-S10
46. Sheth T., Amlani S., Ellins M.L., et al. Computed tomographic coronary angiographic assessment of high-risk coronary anatomy in patients with suspected coronary artery disease and intermediate pretest probability. Am Heart J 155 (2008) 918-923
47. Hendel R.C., Patel M.R., Kramer C.M., et al. ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiography and Interventions, and Society of Interventional Radiology. J Am Coll Cardiol 48 (2006) 1475-1497
48. Min J.K., Shaw L.J., Devereux R.B., et al. Prognostic value of multidetector coronary computed tomographic angiography for prediction of all-cause mortality. J Am Coll Cardiol 50 (2007) 1161-1170
49. Pundziute G., Schuijf J.D., Jukema J.W., et al. Prognostic value of multislice computed tomography coronary angiography in patients with known or suspected coronary artery disease. J Am Coll Cardiol 49 (2007) 62-70
50. Fox C.S., Vasan R.S., Parise H., et al. Mitral annular calcification predicts cardiovascular morbidity and mortality: The Framingham heart study. Circulation 107 (2003) 1492-1496
51. Verdecchia P., Angeli F., Achilli P., et al. Echocardiographic left ventricular hypertrophy in hypertension: Marker for future events or mediator of events?. Curr Opin Cardiol 22 (2007) 329-334
52. Bangalore S., Yao S.S., and Chaudhry F.A. Usefulness of stress echocardiography for risk stratification and prognosis of patients with left ventricular hypertrophy. Am J Cardiol 100 (2007) 536-543
53. Takemoto Y., Barnes M.E., Seward J.B., et al. Usefulness of left atrial volume in predicting first congestive heart failure in patients > or = 65 years of age with well-preserved left ventricular systolic function. Am J Cardiol 96 (2005) 832-836
54. Tsang T.S., Barnes M.E., Gersh B.J., et al. Prediction of risk for first age-related cardiovascular events in an elderly population: the incremental value of echocardiography. J Am Coll Cardiol 42 (2003) 1199-1205
55. Armstrong W.F., and Zoghbi W.A. Stress echocardiography: Current methodology and clinical applications. J Am Coll Cardiol 45 (2005) 1739-1747
56. Pellikka P.A., Nagueh S.F., Elhendy A.A., et al. American Society of Echocardiography recommendations for performance, interpretation, and application of stress echocardiography. J Am Soc Echocardiogr 20 (2007) 1021-1041
57. Park T.H., Tayan N., Takeda K., et al. Supine bicycle echocardiography improved diagnostic accuracy and physiologic assessment of coronary artery disease with the incorporation of intermediate stages of exercise. J Am Coll Cardiol 50 (2007) 1857-1863
58. Gehi A.K., Ali S., Na B., et al. Inducible ischemia and the risk of recurrent cardiovascular events in outpatients with stable coronary heart disease: the heart and soul study. Arch Intern Med 168 (2008) 1423-1428
59. Mazur W., Rivera J.M., Khoury A.F., et al. Prognostic value of exercise echocardiography: Validation of a new risk index combining echocardiographic, treadmill, and exercise electrocardiographic parameters. J Am Soc Echocardiogr 16 (2003) 318-325
60. Shaw L.J., Vasey C., Sawada S., et al. Impact of gender on risk stratification by exercise and dobutamine stress echocardiography: long-term mortality in 4234 women and 6898 men. Eur Heart J 26 (2005) 447-456
61. Elhendy A., Arruda A.M., Mahoney D.W., et al. Prognostic stratification of diabetic patients by exercise echocardiography. J Am Coll Cardiol 37 (2001) 1551-1557
62. Underwood S.R., Anagnostopoulos C., Cerqueira M., et al. Myocardial perfusion scintigraphy: The evidence. Eur J Nucl Med Mol Imaging 31 (2004) 261-291
63. Iskandrian A.S., Chae S.C., Heo J., et al. Independent and incremental prognostic value of exercise single-photon emission computed tomographic (SPECT) thallium imaging in coronary artery disease. J Am Coll Cardiol 22 (1993) 665-670
64. Hachamovitch R., Hayes S.W., Friedman J.D., et al. Stress myocardial perfusion single-photon emission computed tomography is clinically effective and cost effective in risk stratification of patients with a high likelihood of coronary artery disease (CAD) but no known CAD. J Am Coll Cardiol 43 (2004) 200-208
65. Wackers F.J., Young L.H., Inzucchi S.E., et al. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: The DIAD study. Diabetes Care 27 (2004) 1954-1961
66. Nagel E., Lorenz C., Baer F., et al. Stress cardiovascular magnetic resonance: Consensus panel report. J Cardiovasc Magn Reson 3 (2001) 267-281
67. Nagel E., Lehmkuhl H.B., Bocksch W., et al. Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. Circulation 99 (1999) 763-770
68. Jahnke C., Nagel E., Gebker R., et al. Prognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobutamine stress wall motion imaging. Circulation 115 (2007) 1769-1776
69. Hundley W.G., Morgan T.M., Neagle C.M., et al. Magnetic resonance imaging determination of cardiac prognosis. Circulation 106 (2002) 2328-2333
70. Schwitter J., Wacker C.M., van Rossum A.C., et al. MR-IMPACT: Comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial. Eur Heart J 29 (2008) 480-489
71. Costa M.A., Shoemaker S., Futamatsu H., et al. Quantitative magnetic resonance perfusion imaging detects anatomic and physiologic coronary artery disease as measured by coronary angiography and fractional flow reserve. J Am Coll Cardiol 50 (2007) 514-522
72. Plein S., Kozerke S., Suerder D., et al. High spatial resolution myocardial perfusion cardiac magnetic resonance for the detection of coronary artery disease. Eur Heart J (2008) [Epub ahead of print]
73. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
74. Kolodgie F.D., Petrov A., Virmani R., et al. Targeting of apoptotic macrophages and experimental atheroma with radiolabeled annexin V: a technique with potential for noninvasive imaging of vulnerable plaque. Circulation 108 (2003) 3134-3139
75. Tahara N., Kai H., Yamagishi S., et al. Vascular inflammation evaluated by [18F]-fluorodeoxyglucose positron emission tomography is associated with the metabolic syndrome. J Am Coll Cardiol 49 (2007) 1533-1539
76. Kietselaer B.L., Reutelingsperger C.P., Heidendal G.A., et al. Noninvasive detection of plaque instability with use of radiolabeled annexin A5 in patients with carotid-artery atherosclerosis. N Engl J Med 350 (2004) 1472-1473
77. Tawakol A., Migrino R.Q., Bashian G.G., et al. In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol 48 (2006) 1818-1824
78. Tahara N., Kai H., Ishibashi M., et al. Simvastatin attenuates plaque inflammation: Evaluation by fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol 48 (2006) 1825-1831
79. Berry J.D., Liu K., Folsom A.R., et al. Prevalence and progression of subclinical atherosclerosis in younger adults with low short-term but high lifetime estimated risk for cardiovascular disease: the coronary artery risk development in young adults study and multi-ethnic study of atherosclerosis. Circulation 119 (2009) 382-389
80. Naghavi M., Falk E., Hecht H.S., et al. From vulnerable plaque to vulnerable patient-Part III: Executive summary of the screening for Heart Attack Prevention and Education (SHAPE) Task Force report. Am J Cardiol 98 (2006) 2H-15
81. Rumberger J.A., Brundage B.H., Rader D.J., et al. Electron beam computed tomographic coronary calcium scanning: a review and guidelines for use in asymptomatic persons. Mayo Clin Proc 74 (1999) 243-252